Duration of supplementation (weeks) | Frequency | OR (CI 95%) | p |
| Pathologic SOD | ||
≥24 | 3/48 (6.3%) | 2.1 (0.8 - 5.3) | <0.05 |
≥23 | 7/48 (14.6%) | 1.4 (0.8 - 2.4) | 0.163 |
≥22 | 11/48 (22.9%) | 1,2 (0.8 - 1.8) | 0.319 |
≥21 | 18/48 (37.5%) | 1,1 (0.8 - 1.6) | 0.316 |
≥20 | 25/48 (52.1%) | 1,2 (0.9 - 1.7) | 0.196 |
≥19 | 37/48 (77.1%) | 1.2 (0.8 - 1.7) | 0.326 |
| Pathologic oxidized LDL | ||
≥24 | 8/42 (19%) | 7.3 (0.9 - 61.7) | <0.04 |
≥ 23 | 13/42 (31%) | 13.9 (1.7 - 113.03) | <0.01 |
≥22 | 18/42 (42.9%) | 23.3 (2.9 - 186.7) | <0.01 |
≥21 | 24/42 (57.1%) | 5.8 (1.9 - 16.9) | <0.01 |
≥20 | 32/42 (76.2%) | 7.04 (2.5 - 19.7) | <0.001 |
≥19 | 34/42 (81%) | 1.2 (0.4 - 3.7) | 0.494 |